AA is a highly selective and irreversible CYP17 inhibitor of androgen synthesis in the prostate cancer cells, adrenal glands, and testicles, and acts by suppressing CYP17 (the key enzyme in the androgen synthesis pathway). Here, CYP17A1 is linked to Familial prostate cancer.